Tenecteplase or Reteplase as Bridging Thrombolysis Before Thrombectomy in Acute Ischemic Cerebrovascular Events

NCT07748039 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

1440

Enrollment

OTHER

Sponsor class

Conditions

Acute Ischemic Stroke
Large Vessel Occlusion
Anterior Circulation Brain Infarction

Interventions

DRUG: rhTNK-tPA (0.25mg/kg)
DRUG: Reteplase 10 Units (U) plus a second dose of reteplase 10 U
PROCEDURE: No thrombolysis (thrombectomy alone)

Sponsor

Yongjun Wang